Hangzhou Tigermed: Leading Global Clinical Research with Strong Market GrowthDiscover how Hangzhou Tigermed Consulting leads global clinical research with top‑tier services, strong growth, and a 42.7 bn CNY market cap.TIGERMED Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 22/12/2025, 06:45 3 minutes to read
TIGERMED’s Strategic Share Buyback Boosts Market Confidence Amid Health Care Sector SurgeTIGERMED, a company in the Life Sciences Tools & Services sector, is emerging as a strong player in the health care industry, driven by its strategic maneuvers and the bullish trend in the innovative drug segment.TIGERMED Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 30/07/2025, 03:42 3 minutes to read